NovoCure (NVCR) Asset Utilization Ratio (2015 - 2026)
NovoCure (NVCR) posted Asset Utilization Ratio of 0.88 for Q2 2026, up 4.27% sequentially from 0.85 in Q1 2026, and up 74.84% YoY from 0.51 in Q2 2025.
NovoCure (NVCR) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
NovoCure has reported Asset Utilization Ratio for 12 years, with the latest figure at 0.88 in Q2 2026.
- Quarterly Asset Utilization Ratio rose 74.84% year-over-year to 0.88 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.88 (up 74.84% YoY) and the FY2025 annual result came in at 0.64, up 26.38% from the prior year.
- Asset Utilization Ratio rose to 0.88 in Q2 2026 per NVCR's latest filing, from 0.85 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.88 in Q2 2026 and troughed at 0.44 in Q2 2023.
- A 5-year average of 0.52 and a median of 0.47 in 2022 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2023 and 2026: Asset Utilization Ratio dropped 7.71% in 2023, then surged 74.84% in 2026.
- Over 5 years, Asset Utilization Ratio stood at 0.45 in 2022, then retreated by 2.27% to 0.44 in 2023, then climbed by 10.61% to 0.49 in 2024, then advanced by 23.15% to 0.61 in 2025, then surged by 45.94% to 0.88 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.88, 0.85, and 0.61 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 0.42 |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 0.55 |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 0.47 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 0.48 |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 0.76 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 0.57 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 0.80 |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 0.56 |
| 10 | NovoCure | 2.05 Bn | 1.61 Bn | 142.48 Mn | 0.88 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.88 |
| Mar 31, 2026 | 0.85 |
| Dec 31, 2025 | 0.61 |
| Sep 30, 2025 | 0.49 |
| Jun 30, 2025 | 0.51 |
| Mar 31, 2025 | 0.50 |
| Dec 31, 2024 | 0.49 |
| Sep 30, 2024 | 0.47 |
| Jun 30, 2024 | 0.47 |
| Mar 31, 2024 | 0.46 |
| Dec 31, 2023 | 0.44 |
| Sep 30, 2023 | 0.44 |
| Jun 30, 2023 | 0.44 |
| Mar 31, 2023 | 0.44 |
| Dec 31, 2022 | 0.45 |
| Sep 30, 2022 | 0.46 |
| Jun 30, 2022 | 0.47 |
| Mar 31, 2022 | 0.47 |
| Dec 31, 2021 | 0.47 |
| Sep 30, 2021 | 0.49 |